From: alacolo@frontier.net
Date: Mon, 12/11/00
December 11, 2000
In this Philip Morris document,
Beneficial Additive Cigarette, scientists glibly and easily kick around
the idea of medicating the general public for dental caries, reducing anxiety,
cold symptoms, improving moods, etc. through cigarettes. Their frequent
references to how careful they must be not to trigger FDA regulation makes
one realize how important the FDA's "interference" is in protecting people
from physical and chemical tinkering at the hands of the tobacco
industry's "shade-tree pharmacists." [NOTE: The term "shade tree pharmacist" is
my adaptation of the term "shade tree mechanic," which refers to an
untrained person who tinkers with
engines for entertainment].
Notice how ideas like introducing compounds into
cigarettes that reduce oral plaque, freshen breath and reduce
odors are considered good, while Idea #20, brushes off the
obvious:
"Additives to reduce biological acitvity are not
considered worth pursing at this time....The idea might be worth pursuing when
we have identified specific compounds responsible for activity."
Title: Beneficial Additive Cigarette
Type of Document: Internal memo, Philip
Morris
Author: L.F. Meyer
To:
Dr. R.B. Seligman
Date: 19810319
Page
Count: 4
Site: Philip Morris Document Site http://www.pmdocs.com/
Quotes:
As a result of two idea sessions
on developing a cigarette with a beneficial additive, some 22 suggestions were
generated...The Directors met to attempt evaluation of these suggestions...
Ideas 2, 3, 4 & 17:
Cigarettes delivering therapeutic agents,
physiological effects, mood changes, or reducing dental caries, anxiety, colds,
etc. received much discussion. Although cigarette filler is a relatively poor
delivery device, tipping paper can be coated and the agents may be delivered
orally. The questions of potential FDA jurisdiction and PM's inability to
advertise these benefits was raised. Third party publication of beneficial
effects based on their experimentation was suggested as an alternative. However,
before undertaking any program of this nature considering the time, money and
effort that will be required, further delineation and definitive direction is
needed. Many of these suggestions imply long range programs with questionable
payoff if the benefit cannot be advertised.
Ideas 5 &
17:
Advertising the appetite suppressant
characteristic of cigarettes as a benefit or the relief of colds with menthol
cigarettes presents another touchy situation and potential FDA interference.
Third party endorsement is a possibility but it then applies to the total
industry, not just PM, unless of course PM products show up superior and are
noted as such.
Idea 8:
Reduction of stale smoke and butt odors is
already part of a new program...
Idea 9:
A publicity campaign
focusing on the wholesomeness of our current additives is a very delicate
situation in that it could backfire...
Idea 11:
The use of odorless compounds
which only take effect in the mouth through enzymatic reaction was an
interesting concept and should be pursued.
Idea 14:
Breath freshener
either through filler addition or tipping paper application is another good idea
that should be pursued. Care must be taken to avoid claims and potential FDA
regulation.
Idea 18
Parsley as a breath freshener is a
good idea and should be pursued.
Idea 20
Additives to reduce biological
activity are not considered worth pursuing at this time....The idea may be worth
pursuing when we have identified specific compounds responsible for activity.
________________________________________________________________________________
This is a re-post from December 24, 1999
---> To sign up for this service, or to view past
postings, go here:
http://www.smokescreen.org/list/det.cfm?listid=66&menuitem=message
You will have to login or sign up on Smokescreen, a quick and simple
matter. (Scrolling and searching functions are now available for the
archives at this URL. A keyword search will return every posting that
contains that keyword in the body of the message.)
--> To unsubscribe from this list, send a message to
Anne Landman, Regional Program Coordinator & Daily
Document List Editor
American Lung Association of Colorado, West Region
Office
P.O. Box 3154
Grand Junction, CO 81502
(970) 245-2120
afoxland@gj.net
| 
